As of March 2026, some form of medical cannabis (or cannabis-based medicine) is legal in 25 countries across the region, with a further 9 having decriminalised the personal use of cannabis, and 4 having legalised cannabis for recreational use. The European cannabis market grew from €870 million in 2024 to €1.45 billion in 2025 and is projected to surpass €2 billion by 2027.
Read more ›Updated: March 17, 2026
1. Understand the regulatory and legal requirements. Do market research. Australia Cannabis Legalization The Narcotic Drugs Amendment Bill was passed […]
Read more ›Updated: March 10, 2026
With domestic cannabis production surging by 154% and imports skyrocketing by 959% – alongside exponential growth in patient prescriptions – demand for medical cannabis in Australia appears to be strong and poised for sustained upward momentum.
Read more ›Updated: March 10, 2026
New Zealand’s medical cannabis supply has surged in recent years with THC-dominant products now making up the majority of prescriptions. The country’s cannabis industry – including the potential adult-use market – could be worth more than $1.5 billion.
Read more ›Updated: March 9, 2026
The Netherlands officially launched the experimental phase of its “Controlled Cannabis Supply Chain Experiment” on April 7, 2025, becoming the first country in Europe to implement a regulated framework for the commercial cultivation and retail sale of adult-use cannabis.
Read more ›Updated: January 21, 2026